Lakatosh V P, Lazarenko L M, Lyanenko L M, Azarskova M V, Mikhailenko O M, Tkáciková L, Boroda A M
Zabolotny Institute of Microbiology and Virology, National Academy of Sciences of Ukraine, Kiev, Ukraine.
Folia Microbiol (Praha). 1999;44(6):721-5. doi: 10.1007/BF02825669.
T(CD3+)-, B(CD19+)-lymphocytes and their subsets (CD4+, CD8+, CD3+ DR+, CD3- DR+) in peripheral blood of patients with CIN I, CIN II, CIN III and cancer in situ associated with HPV infection were evaluated. In peripheral blood of women with CIN II, CIN III and cancer in situ the number of T-lymphocytes which expressed CD3+ DR+ antigen decreased. In patients with CIN I, CIN III and cancer in situ the level of the CD4+ cells decreased; the level of the CD8+ cells increased. These patients had a lower CD4/CD8 ratio, the number of B cells being standard. The results may have important implications in the prognosis and immunotherapy of HPV infection.
对伴有人乳头瘤病毒(HPV)感染的宫颈上皮内瘤变I级(CIN I)、II级(CIN II)、III级(CIN III)及原位癌患者外周血中的T(CD3 +)、B(CD19 +)淋巴细胞及其亚群(CD4 +、CD8 +、CD3 + DR +、CD3 - DR +)进行了评估。在患有CIN II、CIN III及原位癌的女性外周血中,表达CD3 + DR +抗原的T淋巴细胞数量减少。在患有CIN I、CIN III及原位癌的患者中,CD4 +细胞水平降低;CD8 +细胞水平升高。这些患者的CD4/CD8比值较低,B细胞数量则处于正常水平。这些结果可能对HPV感染的预后及免疫治疗具有重要意义。